| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_e16ce737e66875b530772776d425d4b6
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_30c7a6b38b77453fb467d70d84cbe2e2
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_9e8bf07fd57459044d5a8367b18a059c
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_73b24b771941efe4ddcf6a6d48da7444
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_e6d4d7321e22e3b85d537f2b3f9b1f9b
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_cd80c6be9a4eb5047ae41ef8689e0256 |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2317-34
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2740-15011 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-56983
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-56988
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K14-005
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K16-1045
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-6854
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-577 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-53 |
| filingDate |
2011-04-01-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_728ae9ad4ba9dc151a89dcbd42418763
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_4979df2f1bc80d3d1184ebc78e864eda
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_941935704226f137c51747f3e6e23c54
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ff25fc92d01e81180e0a368167059e7e
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_19de109309aca53070b2f7ed09477800 |
| publicationDate |
2011-10-06-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
WO-2011123781-A1 |
| titleOfInvention |
Detection of feline immunodeficiency virus |
| abstract |
Method, device and kit for the detection of antibodies directed to Feline Immunodeficiency Virus (FIV). The method includes contacting the felid biological sample with FIV env polypeptide and detecting whether the polypeptide substantially binds to the antibody in the biological sample. The method will detect FIV antibodies in a sample from animals that have been naturally infected but the method will not detect antibodies in a sample from animals that have not been infected and that have not been vaccinated with an FIV vaccine after within about the previous five to eight weeks. |
| priorityDate |
2010-04-02-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |